Pitolisant 17.8mg Tablets
Tablets · 30 Tablets per Box
- Composition
- Pitolisant
- Manufacturer
- MSN Labs
- Pack
- 30 Tablets per Box
- Order within -- and we dispatch today
About Pitolisant 17.8mg Tablets
Pitolisant 17.8mg Tablets contain pitolisant, a prescription medicine used to manage narcolepsy-related excessive daytime sleepiness and cataplexy. Wakix is the established branded product, with generic pitolisant tablets also approved in the USA.
Customers searching for Pitolisant 17.8mg price, Wakix tablets, product availability or pharmacy supply should confirm the current price, exact formulation, pack details and prescription requirements with an authorized pharmacy.
Product Information
| Detail | Information |
|---|---|
| Generic Name | Pitolisant |
| Brand Reference | Wakix |
| Active Ingredient | Pitolisant hydrochloride equivalent to 17.8mg pitolisant |
| Strength | 17.8mg |
| Regional Label Strength | 18mg in some European product information |
| Dosage Form | Film-Coated Tablet |
| Drug Class | H3 Receptor Antagonist/Inverse Agonist |
| Route | Oral |
| Therapeutic Category | Sleep Disorders |
| Indication | Narcolepsy-related symptoms, subject to local labeling |
| Administration | Once daily as prescribed |
| Prescription | Required |
| Pack Size | Market-dependent |
| Price | Confirm current local pharmacy pricing |
| Availability | Subject to authorization and stock |
Why Choose Pitolisant 17.8mg Tablets?
-
Recognized brand reference: Wakix.
-
Specified tablet strength: 17.8mg pitolisant.
-
Established prescription medicine: Used in the management of narcolepsy.
-
Product verification: Confirm the strength, formulation and packaging before purchase.
-
International supply enquiries: Verify authorized pharmacy availability in the destination country.
Pitolisant 17.8mg Price and Ordering Information
Pitolisant pricing varies by country, brand, supplier, pack size and healthcare coverage. Contact an authorized pharmacy to confirm the current Pitolisant 17.8mg price, Wakix availability and dispensing requirements.
Before ordering, verify product registration, packaging, expiry date and legal supply conditions. Pitolisant is a prescription medicine and should be obtained through authorized channels.
Generic Pitolisant 17.8mg vs Wakix
Wakix is the established branded pitolisant product. Generic pitolisant tablets are available in certain markets, including the USA.
Products may differ in manufacturer, packaging and regulatory status. Confirm the active ingredient, strength, formulation and authorization before considering a substitution.
Pitolisant 17.8mg — Availability by Country
| Country | Status | Commercial Information |
|---|---|---|
| USA | Approved market | Wakix and approved generic pitolisant tablets; confirm pharmacy stock |
| UK | Authorized branded product market | Check Wakix pricing and prescription requirements |
| Australia | Local registration and supply require verification | Confirm current authorization and pharmacy availability |
| UAE / Dubai | Local authorization requires verification | Check registration and licensed pharmacy supply |
| Germany | Authorized EU product market | Search for Wakix 18mg, the regional label strength corresponding to 17.8mg pitolisant |
| France | Authorized EU product market | Check Wakix 18mg pricing and pharmacy supply |
| Russia | Current registration requires verification | Confirm national authorization and legal supply |
| South Korea | Current product availability requires verification | Check local registration and dispensing requirements |
| Japan | Current product availability requires verification | Confirm authorized product status |
| Worldwide | Market-dependent | Verify local registration, prescription requirements and authorized supply |
Dosage and how to take it
Pitolisant is administered orally, generally once daily in the morning under the applicable prescribing information. The dose is usually introduced and adjusted gradually according to clinical response, tolerability and patient-specific factors.
Renal or hepatic impairment and interactions with other medicines can affect the appropriate dose. Follow the prescription and local product information; do not change the dose independently.
Safety
Common adverse effects may include headache, insomnia, nausea and anxiety. Pitolisant can prolong the QT interval and interact with medicines that affect its metabolism.
Inform the prescribing clinician about heart rhythm conditions, kidney or liver problems, pregnancy, breastfeeding and all other medicines being taken. Medical monitoring may be required during treatment.
This product information is provided for commercial and educational reference purposes only. Pitolisant 17.8mg is a prescription medicine that must be used under qualified medical supervision. Approved indications, prices, availability and dispensing requirements vary by country. Verify the exact product and legal supply conditions before purchase.
Last Updated: October 22, 2026
Reviews
More products with Pitolisant
Compare medicines with the same composition.





members who have received this product can leave the first review. join to see if you can.